Pharmaceutical products
Original notice title
Bulgaria-Sofia: Pharmaceutical products
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- BGN 8.7M estimated value
- Supplies contract
- Supply of various pharmaceutical products to Pirogov Hospital, Sofia.
- Products are grouped into nomenclature units (sub-lots), but no detailed list provided in the notice.
Show full summary
Establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to Pirogov Hospital in Sofia, Bulgaria. The DPS has an estimated total value of 8,695,574 BGN and a duration of 36 months (until 29 December 2026). This is a restricted procedure, with award based on lowest price. Eligibility includes a minimum turnover of 100,000 BGN over the last three years and possession of a wholesale distribution license. The notice is a DPS creation, and no specific lot breakdown is provided; the system covers multiple nomenclature units. Procurement documents were not analyzed.
Risks
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- No technical or professional capacity requirement is imposed.
Eligibility
- Minimum total turnover of 100,000 BGN over the last three financial years.
Certifications
- Tenderers must hold a wholesale distribution license for pharmaceuticals or equivalent, as per Bulgarian law.
Requirements may be incomplete.
Buyer
Location
гр. София, BGR
Website
Buyer profile
Identifier
130345786
Activity
Health
Procurement Details
- Publication date
- 02 Jan 2024
- Languages
- Bulgarian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 3311-2024
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications